🟡 60/100

Review before taking

  • Beta-Nicotinamide Mononucleotide: 250mg is 7.1× the Tolerable Upper Intake Level (35mg)
  • 100% of ingredients have research evidence
C Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Safety Alerts

⚠️ Beta-Nicotinamide Mononucleotide: 250mg is 7.1× the Tolerable Upper Intake Level (35mg)

The safety score is low because the amount of NMN in this supplement is over seven times higher than the recommended maximum daily limit.

Label Data

250 mg Serving Size
40 Servings
Non-Nutrient/Non-Botanical Product Type
100% Evidence Coverage

Supplement Facts — Evidence Check

⚠️ Exceeds Tolerable Upper Intake Level by 7.1× (UL: 35 mg) 📚 193 studies (Tier A: 5, B: 63)
RDA 14mg This product: 250mg UL 35mg

Label Claims — Verification

All Other
Structure/Function
All Other (100% of products) Structure/Function (90% of products) Nutrient (2% of products)

Target Groups

Adult (18 - 50 Years) Gluten Free Dairy Free

Product Information

📋 Directions for Use

Suggested Use: As a dietary supplement, take 250 mg (about 1/10 tsp) once daily, or as directed by a physician.

⚠️ Warnings & Precautions

Always consult a physician before taking any dietary supplement.

Keep out of reach of children.

🧪 Formulation Notes

Free of: Added sugar, soy, dairy, yeast, gluten, additives

Additional Information

Use an accurate milligram scale. Contents are sold by weight, not volume. Settling may occur. New

Store in a dry, cool place

Product Details

UPC / SKU X002NDKZ5D
DSLD Entry Date 2024-04-23
Product Type Non-Nutrient/Non-Botanical
Form Powder
DSLD ID 311131
Data Updated 2026-04-11

Research Evidence

8 Research Sources
54 Avg Quality Score
4 Rct
2 Meta Analysis
2 Clinical Trial
B Efficacy of oral nicotinamide mononucleotide supplementation on glucose and lipid metabolism for adults: a systematic review with meta-analysis on randomized controlled trials
Meta Analysis Critical reviews in food science and nutrition 2025
B Ingestion of β-nicotinamide mononucleotide increased blood NAD levels, maintained walking speed, and improved sleep quality in older adults in a double-blind randomized, placebo-controlled study
Rct GeroScience 2024
C Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women.
Rct Science (New York, N.Y.)
C The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial.
Rct GeroScience
C Effects of Nicotinamide Mononucleotide on Glucose and Lipid Metabolism in Adults: A Systematic Review and Meta-analysis of Randomised Controlled Trials
Meta Analysis Current diabetes reports 2024
C Nicotinamide adenine dinucleotide metabolism and arterial stiffness after long-term nicotinamide mononucleotide supplementation: a randomized, double-blind, placebo-controlled trial
Rct Scientific reports 2023
C Safety and Pharmacokinetics of Nicotinamide Mononucleotide (NMN) in Healthy Adults.
Clinical Trial ClinicalTrials.gov 2021
C Effect of 'Nicotinamide Mononucleotide' (NMN) on Cardiometabolic Function
Clinical Trial ClinicalTrials.gov 2017
View all evidence for Nmn →

Compare Similar Products

View all Nmn products →